Love Selfies? Now They Can Keep Your Credit Card Safe
MasterCard is appealing to America’s obsession with selfies in an effort to reduce credit card identity theft.
The credit card company is launching a new program that will allow consumers to approve online purchases with a facial scan. At the checkout page, you’ll be asked to take a picture of yourself using your phone instead of entering a password.
Currently, customers can stop hackers from using their credit card on the Web by setting up a “SecureCode,” which requires a password when shopping online. The password system was used in 3 billion transactions last year.
This fall MasterCard will launch a small pilot program involving 500 customers using fingerprints and facial scans. If the test is a success, the company plans on rolling it out publicly afterward. The company is also looking ahead to one day apply voice recognition technology.
To use the new selfie system, customers need to download the MasterCard phone app. Once you pay for something, a pop-up will appear asking for your authorization with either a fingerprint or facial recognition. Using facial recognition, customers stare at the phone, blink once — and bam! All done. The blink is a security measure so thieves can’t just hold up a photo of you. A fingerprint only requires a touch.
Passwords are easily forgotten, stolen or cracked, so the new system is a way to prove your identity using biometrics. Critics of the new system are uncomfortable that the photo or fingerprint a customer puts into his or her phone will transmit to the company’s computer servers. Cybersecurity experts worry the transfer of such information across devices is too big of a privacy risk.
MasterCard wasn’t the first company to develop a facial recognition app — Chinese shopping brand Alibaba demonstrated one in March, but had to postpone the technology’s launch because of security risks found by China’s central bank and police ministry.
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
